Annals of Emergency Medicine
Volume 43, Issue 3 , Pages 339-340 , March 2004

Update on emerging infections: News from the centers for disease control and prevention

References 

    References
  1. Centers for Disease Control and Prevention . Approval of a new rapid test for HIV antibody. MMWR Morb Mortal Wkly Rep. 2002;51:1051–1052
  2. Minkoff H, O'Sullivan MJ. The case for rapid HIV testing during labor. (JAMA), 1998;279:1743–1745
  3. Centers for Disease Control and Prevention . US public health service task force recommendations for use of antiretroviral drugs in pregnant HIV-1–infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Morb Mortal Wkly Rep. 2002;51:RR18
  4. Cohen MH, Olszewski Y, Branson B, et al.  Using point-of-care testing to make rapid HIV-1 tests in labor really rapid. (AIDS), 2003;17:2121–2124
  5. Kourtis AP, Bulterys M, Nesheim SR, et al.  Understanding the timing of HIV transmission from mother to infant. (JAMA), 2001;285:709–712
  6. Moodley D, Moodley J, Coovadia H, et al.  A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 2003;187:725–735
  7. Centers for Disease Control and Prevention . Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329–332
  8. National Committee for Clinical Laboratory Standards . In: Point-of-care in vitro diagnostic (IVD) testing; approved guideline. Wayne, PA: National Committee for Clinical Laboratory Standards; 1999; NCCLS document AST2-A.
  9. Humbertson SK. Management of a point-of-care program. Organization, quality assurance, and data management. Clin Lab Med. 2001;21:255–268
  10. Stringer JS, Rouse DJ. Rapid testing and zidovudine treatment to prevent vertical transmission of HIV in unregistered parturients: a cost-effectiveness analysis. Obstet Gynecol. 1999;94:34–40

☆ Section EditorsDavid A. Talan, MDGregory J. Moran, MDOlive View–UCLA Medical Center, Sylmar, CARobert Pinner, MDCenters for Disease Control and Prevention, Atlanta, GAEditor's note: This article is part of a regular series on emerging infections from the Centers for Disease Control and Prevention (CDC) and the EMERGEncy ID NET, an emergency department–based and CDC-collaborative surveillance network. Important infectious disease public health information with relevance to emergency physicians is reported. The goal of this series is to advance knowledge about communicable diseases in emergency medicine and foster cooperation between the front line of clinical medicine and public health agencies.[Centers for Disease Control and Prevention. Rapid point-of-care testing for HIV-1 during labor and delivery—Chicago, Illinois, 2002.

PII: S0196-0644(03)01334-9

doi: 10.1016/j.annemergmed.2003.12.011

Annals of Emergency Medicine
Volume 43, Issue 3 , Pages 339-340 , March 2004

Article Tools